CADL
Candel Therapeutics Inc
11.30$
-4.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +0.0% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | |
| – | -94.5% | -19.6% | +1,831.1% | +8.8% | -95.4% | +0.0% | -1.2% | -19.4% | -16.4% | -8.6% | – | – | |
| – | – | -117.1% | – | – | – | – | – | – | – | – | – | – | |
| – | +18.8% | -40.9% | +21.4% | +8.8% | -11.1% | -16.6% | +74.1% | +21.0% | +30.3% | -10.8% | +101.2% | – | |
| – | +1.5% | +24.2% | -5.5% | -7.0% | -0.5% | +23.8% | +1.8% | +13.4% | -0.5% | +36.4% | +7.8% | – | |
| – | +12.9% | -21.0% | +8.5% | +2.2% | -7.0% | -0.1% | +37.5% | +18.2% | +19.3% | +3.4% | +64.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.6% | -4.0% | -12.2% | -14.1% | -19.9% | -21.5% | -22.9% | -31.8% | +779.5% | +10.5% | +0.7% | – | |
| – | – | – | – | – | – | – | -165.0% | – | – | – | – | – | |
| – | – | -46.2% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -165.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | -154.5% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.